CRISPR Therapeutics, Inc Technographics

Discover the latest software purchases and digital transformation initiatives being undertaken by CRISPR Therapeutics, Inc and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 458 CRISPR Therapeutics, Inc employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.

During our research, we have identified that CRISPR Therapeutics, Inc has purchased the following applications: Microsoft Azure Cloud Services for Application Hosting and Computing Services in 2014, Algolia Search for Application, Web and Enterprise Search in 2020, Rocket.chat for Chatbots and Conversational AI in 2018 and the related IT decision-makers and key stakeholders.

Our database provides customer insight and contextual information on which enterprise applications and software systems CRISPR Therapeutics, Inc is running and its propensity to invest more and deepen its relationship with Microsoft , Algolia , Rocket.chat or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.

We have been analyzing CRISPR Therapeutics, Inc revenues, which have grown to $439.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for CRISPR Therapeutics, Inc intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.